Show
Sort by
-
- Journal Article
- A1
- open access
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting : a randomized placebo-controlled phase II trial
-
- Journal Article
- A1
- open access
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
-
- Journal Article
- A1
- open access
A role for B cells to transmit hepatitis C virus infection
-
A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody
-
- Journal Article
- A1
- open access
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : a phase 1 randomized clinical trial
-
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β
-
Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
-
Customized protein glycosylation to improve biopharmaceutical function and targeting
-
- Journal Article
- A1
- open access
A DNA prime immuno-potentiates a modified live vaccine against the porcine reproductive and respiratory syndrome virus but does not improve heterologous protection
-
- Journal Article
- A1
- open access
No evidence for a role for antibodies during vaccination-induced enhancement of porcine reproductive and respiratory syndrome
-
- Journal Article
- A1
- open access
Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
-
Functional study of the C-terminal part of the hepatitis C virus E1 ectodomain
-
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
-
- Journal Article
- A2
- open access
Modified-live PRRSV subtype 1 vaccine UNISTRAIN® PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena
-
- Journal Article
- A1
- open access
Immunity raised by recent European subtype 1 PRRSV strains allows better replication of East European subtype 3 PRRSV strain Lena than that raised by an older strain
-
- Journal Article
- A1
- open access
Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis
-
Identification of a new benzimidazole derivative as an antiviral against hepatitis C virus
-
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
-
Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: what can be learnt from other diseases?
-
Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena
-
- Journal Article
- A1
- open access
Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge
-
- Journal Article
- A1
- open access
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
-
Autochthonous tick-borne encephalitis virus-seropositive cattle in Belgium: a risk-based targeted serological survey
-
- Journal Article
- A1
- open access
Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity
-
Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines
-
Evaluation of viral peptide targeting to porcine sialoadhesin using a porcine reproductive and respiratory syndrome virus vaccination-challenge model
-
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
-
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice
-
Blocking HCV entry as potential antiviral therapy
-
- Journal Article
- A1
- open access
Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges
-
Micro-dissecting the pathogenesis and immune response of PRRSV infection paves the way for more efficient PRRSV vaccines
-
Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies
-
Aujeszky's disease (pseudorabies): an old threat in current pig industry?, part II : epidemiology, immunity, prevention and the current situation in Greece
-
Porcine reproductive and respiratory syndrome virus (PRRSV)-specific mAbs: supporting diagnostics and providing new insights into the antigenic properties of the virus
-
- Journal Article
- A1
- open access
HCV animal models : a journey of more than 30 years
-
The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV
-
- Journal Article
- A1
- open access
Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit